Shanler Stuart
Insider CIK 1654332 · ACRS Chief Scientific Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2019-03-01 | 2019-03-04 | 82,200 | — | $0 | 82,200 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2019-02-01 | 2019-02-05 | 3,875 | — | $0 | 11,625 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | F Tax w/h | 2019-02-01 | 2019-02-05 | 1,308 | $6.96 | $9.1K | 272,047 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2019-02-01 | 2019-02-05 | 3,875 | — | $0 | 273,355 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2018-12-18 | 2018-12-21 | 1,450 | — | $0 | 1,450 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | F Tax w/h | 2018-12-18 | 2018-12-21 | 412 | $6.30 | $2.6K | 269,480 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2018-12-18 | 2018-12-21 | 1,450 | — | $0 | 269,892 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2018-12-15 | 2018-12-18 | 1,300 | — | $0 | 2,600 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | F Tax w/h | 2018-12-15 | 2018-12-18 | 370 | $7.31 | $2.7K | 268,442 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2018-12-15 | 2018-12-18 | 1,300 | — | $0 | 268,812 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2018-05-07 | 2018-05-09 | 5,200 | — | $0 | 3,900 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2018-05-07 | 2018-05-09 | 5,200 | — | $0 | 268,992 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | F Tax w/h | 2018-05-07 | 2018-05-09 | 1,480 | $18.10 | $26.8K | 267,512 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2018-02-01 | 2018-02-05 | 15,500 | — | $0 | 15,500 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2018-02-01 | 2018-02-05 | 54,000 | — | $0 | 54,000 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2017-12-18 | 2017-12-21 | 1,450 | — | $0 | 2,900 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2017-12-18 | 2017-12-21 | 1,450 | — | $0 | 264,233 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | F Tax w/h | 2017-12-18 | 2017-12-21 | 441 | $24.12 | $10.6K | 263,792 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2017-12-15 | 2017-12-21 | 1,300 | — | $0 | 9,100 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | F Tax w/h | 2017-12-15 | 2017-12-21 | 395 | $24.23 | $9.6K | 262,783 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2017-12-15 | 2017-12-21 | 1,300 | — | $0 | 263,178 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2016-12-18 | 2016-12-20 | 1,450 | — | $0 | 4,350 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2016-12-18 | 2016-12-20 | 1,450 | — | $0 | 262,319 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | F Tax w/h | 2016-12-18 | 2016-12-20 | 441 | $31.25 | $13.8K | 261,878 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2016-12-15 | 2016-12-19 | 62,400 | — | $0 | 62,400 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2016-12-15 | 2016-12-19 | 10,400 | — | $0 | 10,400 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2015-12-18 | 2015-12-22 | 53,833 | — | $0 | 53,833 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2015-12-18 | 2015-12-22 | 5,800 | — | $0 | 5,800 | SEC↗ |